MBX Biosciences Inc. Comm... (MBX)
MBX Biosciences Common Stock Max Pain By Strike
MBX trades at $14.74, 17.9% above the near-term max pain of $12.5 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2.5-$12.5), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 6 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
MBX Biosciences Common Stock Max Pain By Expiry
Max pain for MBX shows an upward trend from 2.5 to 12.5, suggesting bullish positioning in longer-dated options. The 163% spread signals divergent expectations across timeframes. Most levels below 14.74 may cap rallies. Strong magnetic level at 3 (6 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 12.5 | -2.24 (-15.20%) |
| Oct 17, 2025 | 12.5 | -2.24 (-15.20%) |
| Nov 21, 2025 | 7.5 | -7.24 (-49.12%) |
| Dec 19, 2025 | 10 | -4.74 (-32.16%) |
| Jan 16, 2026 | 10 | -4.74 (-32.16%) |
| Feb 20, 2026 | 2.5 | -12.24 (-83.04%) |
| Mar 20, 2026 | 2.5 | -12.24 (-83.04%) |
| Apr 17, 2026 | 2.5 | -12.24 (-83.04%) |
| May 15, 2026 | 2.5 | -12.24 (-83.04%) |
| Jul 17, 2026 | 2.5 | -12.24 (-83.04%) |
| Dec 18, 2026 | 2.5 | -12.24 (-83.04%) |